Evolution of a Unified Strategy for Complex Sesterterpenoids: Progress toward Astellatol and the Total Synthesis of (-)-Nitidasin

  1. Hog, D.T. 12
  2. Huber, F.M.E. 2
  3. Jiménez-Osés, G. 3
  4. Mayer, P. 2
  5. Houk, K.N. 3
  6. Trauner, D. 2
  1. 1 Bayer Health Care, Bayer Pharma AG, BPH-GDD-CGEI-MCB-MCII, Müllerstr.178, Berlin, Germany
  2. 2 Ludwig Maximilian University of Munich
    info

    Ludwig Maximilian University of Munich

    Múnich, Alemania

    ROR https://ror.org/05591te55

  3. 3 University of California Los Angeles
    info

    University of California Los Angeles

    Los Ángeles, Estados Unidos

    ROR https://ror.org/046rm7j60

Revista:
Chemistry - A European Journal

ISSN: 0947-6539

Año de publicación: 2015

Volumen: 21

Número: 39

Páginas: 13646-13665

Tipo: Artículo

DOI: 10.1002/CHEM.201501423 SCOPUS: 2-s2.0-84941599149 GOOGLE SCHOLAR

Otras publicaciones en: Chemistry - A European Journal

Resumen

Astellatol and nitidasin belong to a subset of sesterterpenoids that share a sterically encumbered trans-hydrindane motif with an isopropyl substituent. In addition, these natural products feature intriguing polycyclic ring systems, posing significant challenges for chemical synthesis. Herein, the evolution of our stereoselective strategy for isopropyl trans-hydrindane sesterterpenoids is detailed. These endeavors included the synthesis of several building blocks, enabling studies toward all molecules of this terpenoid subclass, and of advanced intermediates of our initial route toward a biomimetic synthesis of astellatol. These findings provided the basis for a second-generation and a third-generation approach toward astellatol that eventually culminated in the enantioselective total synthesis of (-)-nitidasin. In particular, a series of substrate-controlled transformations to install the ten stereogenic centers of the target molecule was orchestrated and the carbocyclic backbone was forged in a convergent fashion. Furthermore, the progress toward the synthesis of astellatol is disclosed and insights into some observed yet unexpected diastereoselectivities by detailed quantum-mechanical calculations are provided. Two and a half molecules: Astellatol and nitidasin are polycyclic sesterterpenoids, posing considerable challenges for synthetic chemists. In this full account, the evolution of a synthetic strategy for these and structurally related natural products is given (see scheme). The presented work includes efforts toward a biomimetic synthesis of astellatol, a successful route for the first total synthesis of (-)-nitidasin, and quantum-mechanical investigations into unexpected diastereosectivities. © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.